{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:28:58Z","timestamp":1786325338238,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117129","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:00:13Z","timestamp":1784239213000},"page":"117129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dihydromyricetin attenuates cholestatic liver injury by suppressing JAK2\/STAT3-associated NF-\u03baB inflammatory and apoptotic signaling"],"prefix":"10.1016","volume":"186","author":[{"given":"Yongkang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sansan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqiao","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.117129_bb0005","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7861\/clinmed.2020-0697","article-title":"An update on the management of cholestatic liver diseases","volume":"20","author":"Appanna","year":"2020","journal-title":"Clin. Med."},{"key":"10.1016\/j.intimp.2026.117129_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jhep.2004.12.014","article-title":"Cholestatic hepatocellular injury: what do we know and how should we proceed","volume":"42","author":"Guicciardi","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2026.117129_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111133","article-title":"Inflammation: cause or consequence of chronic cholestatic liver injury","volume":"137","author":"Woolbright","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.intimp.2026.117129_bb0020","first-page":"423","article-title":"Review: pathogenesis of cholestatic liver diseases, world","volume":"12","author":"Yokoda","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2026.117129_bb0025","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/HEP.0000000000001052","article-title":"Drug-induced cholestatic liver diseases","volume":"82","author":"Bjornsson","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.117129_bb0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/HEP.0000000000001438","article-title":"Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver disease","volume":"82","author":"Trauner","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.117129_bb0035","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.intimp.2026.117129_bb0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2026.117129_bb0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.intimp.2026.117129_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5582\/bst.2018.01247","article-title":"Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury","volume":"13","author":"Zhang","year":"2019","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.intimp.2026.117129_bb0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.14218\/JCTH.2022.00147","article-title":"Chinese Society of Hepatology and Chinese Medical Association, guidelines for the management of cholestatic liver diseases (2021)","volume":"10","author":"Lu","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.intimp.2026.117129_bb0060","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3390\/biomedicines11061713","article-title":"Current therapies for cholestatic diseases","volume":"11","author":"M\u00e9ndez-S\u00e1nchez","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.117129_bb0065","author":"WFO"},{"key":"10.1016\/j.intimp.2026.117129_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.tifs.2025.104939","article-title":"Vine tea (ampelopsis grossedentata) \u2014 a different kind of tea hidden deep in the mountains of China: a comprehensive review of the nutritional profile, functional effect, and diverse applications as a novel raw material in food practices","volume":"159","author":"Zhang","year":"2025","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.intimp.2026.117129_bb0075","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3390\/foods14122011","article-title":"Inhibitory mechanisms of vine tea extract and dihydromyricetin against escherichia coli: a multidimensional analysis from cell membrane to protein synthesis","volume":"14","author":"Ma","year":"2025","journal-title":"Foods"},{"key":"10.1016\/j.intimp.2026.117129_bb0080","doi-asserted-by":"crossref","unstructured":"Ruirui Zhang, Hao Zhang, Houyin Shi, Dan Zhang, Zhuo Zhang & Hao Liu (2022) Strategic developments in the drug delivery of natural product dihydromyricetin: applications, prospects, and challenges, Drug Delivery, 29:1, 3052-3070, DOI: 10.1080\/10717544.2022.2125601.","DOI":"10.1080\/10717544.2022.2125601"},{"key":"10.1016\/j.intimp.2026.117129_bb0085","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.4014\/jmb.2406.06048","article-title":"Dihydromyricetin alleviates non-alcoholic fatty liver disease by modulating gut microbiota and inflammatory signaling pathways","volume":"34","author":"Kang","year":"2024","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2026.117129_bb0090","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.3748\/wjg.v21.i18.5473","article-title":"Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice","volume":"21","author":"Xie","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.intimp.2026.117129_bb0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12967-024-05060-7","article-title":"Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK\/PGC-1\u03b1 and PPAR\u03b1-mediated autophagy pathway","volume":"22","author":"Yang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2026.117129_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.psj.2025.105034","article-title":"Dihydromyricetin ameliorates lipopolysaccharide\u2013induced hepatic injury in chickens by activating the Nrf2\/Keap1 pathway and regulating mitochondrial dynamics","volume":"104","author":"Yuan","year":"2025","journal-title":"Poult. Sci."},{"key":"10.1016\/j.intimp.2026.117129_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156522","article-title":"Dihydromyricetin regulates the miR-155-5p\/SIRT1\/VDAC1 pathway to promote liver regeneration and improve alcohol-induced liver injury","volume":"139","author":"Ma","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2026.117129_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1488003","article-title":"Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems","volume":"15","author":"He","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2026.117129_bb0115","first-page":"774","article-title":"Hepatic GDP-fucose transporter SLC35C1 attenuates cholestatic liver injury and inflammation by inducing CEACAM1 N153 fucosylation","volume":"81","author":"Zhang","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.117129_bb0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41420-023-01326-z","article-title":"Hepatic TNFRSF12A promotes bile acid-induced hepatocyte pyroptosis through NF\u03baB\/caspase-1\/GSDMD signaling in cholestasis","volume":"9","author":"Liao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.117129_bb0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bcpt.12449","article-title":"Bile acid-induced toxicity in hepa <span style=\u201cfont-variant:small-caps;\u201d>RG<\/span> cells recapitulates the response in primary human hepatocytes","volume":"118","author":"Woolbright","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.intimp.2026.117129_bb0130","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2026.117129_bb0135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1517\/17425255.2012.685159","article-title":"The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human","volume":"8","author":"Andersson","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.intimp.2026.117129_bb0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and autodock\/vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.intimp.2026.117129_bb0145","article-title":"Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury","volume":"4","author":"Cai","year":"2017","journal-title":"Inflamm. Cell Signal."},{"key":"10.1016\/j.intimp.2026.117129_bb0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12986-021-00589-6","article-title":"Dihydromyricetin ameliorates liver fibrosis via inhibition of hepatic stellate cells by inducing autophagy and natural killer cell-mediated killing effect","volume":"18","author":"Zhou","year":"2021","journal-title":"Nutr. Metab."},{"key":"10.1016\/j.intimp.2026.117129_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1201007","article-title":"Dihydromyricetin supplementation improves ethanol-induced lipid accumulation and inflammation","volume":"10","author":"Janilkarn-Urena","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.intimp.2026.117129_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40168-022-01458-x","article-title":"Gut microbiota-derived ursodeoxycholic acid alleviates low birth weight-induced colonic inflammation by enhancing M2 macrophage polarization","volume":"11","author":"Pi","year":"2023","journal-title":"Microbiome"},{"key":"10.1016\/j.intimp.2026.117129_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-026-01800-y","article-title":"Dysregulation of the TFEB-ATP6V0C axis in microglia exacerbates \u03b1-synuclein pathology through impaired lysosomal acidification in parkinson\u2019s disease","author":"Wang","year":"2026","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.117129_bb0170","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2026.117129_bb0175","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.3390\/ijms19082299","article-title":"Contribution of STAT3 to inflammatory and fibrotic diseases and prospects for its targeting for treatment","volume":"19","author":"Kasembeli","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:44:13Z","timestamp":1786322653000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S1567576926009756"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117129","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydromyricetin attenuates cholestatic liver injury by suppressing JAK2\/STAT3-associated NF-\u03baB inflammatory and apoptotic signaling","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117129","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117129"}}